ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Full Enrollment In 300-Subject Multicenter Phase 2b Clinical Trial
WESTON, Fla.--(BUSINESS WIRE)--Oct 8, 2019-- |!| Ludington
WESTON, Fla.--(BUSINESS WIRE)--Oct 8, 2019-- |!| Ludington